HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guido Maura Selected Research

Weight Loss (Weight Reduction)

9/2013Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guido Maura Research Topics

Disease

4Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018 - 07/2002
3Gliosis
01/2022 - 03/2016
3Ischemia
11/2004 - 08/2003
3Brain Ischemia (Cerebral Ischemia)
11/2004 - 08/2003
2Seizures (Absence Seizure)
01/2022 - 03/2016
2Brain Injuries (Brain Injury)
03/2016 - 01/2013
1Epilepsy (Aura)
01/2022
1Neuroinflammatory Diseases
01/2021
1Parkinson Disease (Parkinson's Disease)
08/2018
1Stroke (Strokes)
10/2016
1Colonic Neoplasms (Colon Cancer)
10/2015
1Neoplasms (Cancer)
10/2015
1Neuralgia (Stump Neuralgia)
10/2015
1Pain (Aches)
10/2015
1Disease Progression
09/2013
1Body Weight (Weight, Body)
09/2013
1Weight Loss (Weight Reduction)
09/2013
1Neuroblastoma
01/2012

Drug/Important Bio-Agent (IBA)

6Glutamic Acid (Glutamate)FDA Link
03/2016 - 08/2003
3Polyamine OxidaseIBA
01/2022 - 03/2016
31,2-cyclohexanediamine (dach)IBA
01/2022 - 03/2016
3Adenosine (Adenocard)FDA LinkGeneric
08/2018 - 08/2003
3D-Aspartic Acid (D Aspartate)IBA
11/2004 - 08/2003
2Kainic Acid (Kainate)IBA
03/2016 - 01/2013
25- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
11/2004 - 08/2003
2Tetrodotoxin (Tetradotoxin)IBA
11/2004 - 08/2003
1SpermineIBA
01/2022
1Ionotropic Glutamate ReceptorsIBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2022
1PolyaminesIBA
01/2021
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2018
1NeuroglobinIBA
10/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2015
1brilliant blue (brilliant blue FCF)IBA
10/2015
1Therapeutic UsesIBA
09/2013
1Coloring Agents (Dyes)IBA
09/2013
1Superoxide Dismutase-1IBA
09/2013
1Purinergic P2X7 ReceptorsIBA
09/2013
1coomassie Brilliant BlueIBA
09/2013
1EnzymesIBA
01/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012
1CalpainIBA
01/2012
1Nitric Oxide Synthase (NO Synthase)IBA
01/2012
1HMGB1 Protein (HMG1)IBA
01/2012
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2004
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2004
1Egtazic Acid (EGTA)IBA
11/2004
1Serotonin (5 Hydroxytryptamine)IBA
10/2004
1Serotonin ReceptorsIBA
10/2004
1benzyloxyaspartate (TBOA)IBA
08/2003
1Neuroprotective AgentsIBA
08/2003
11,3-dipropyl-8-cyclopentylxanthineIBA
08/2003
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
08/2003
1IonsIBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2002
1Superoxides (Superoxide)IBA
07/2002
1Peroxynitrous Acid (Peroxynitrite)IBA
07/2002
1Oxidants (Oxidizing Agents)IBA
07/2002

Therapy/Procedure

1Catheters
10/2015